Peer-reviewedLicence not statedMMWR. Morbidity and mortality weekly report
Notes from the Field: Investigation of Unapproved Botulinum Toxin Product Administered at a Medical Spa - Colorado, 2025-2026.
Related
- Cell Viability of the Administered Product Predicts Response to Stromal Vascular Fraction in Patients with Erectile Dysfunction Unresponsive to Phosphodiesterase Type 5 Inhibitors
- Modifiable drivers of community pharmacy closures in Colorado and Utah: a qualitative focus group study.
- The Fertility Reduction Effects of the Colorado Family Planning Initiative by Age and Parity
- Bulging of the Masseter Muscle Following Botulinum Neurotoxin Type A Injection
- The motor endplate band as an optimal target for botulinum toxin in congenital torticollis: evidence from a rabbit model
BibTeX
@article{oruganti2026notes,
title = {{Notes from the Field: Investigation of Unapproved Botulinum Toxin Product Administered at a Medical Spa - Colorado, 2025-2026.}},
author = {Pallavi Oruganti and Natalia G Riemer and Cayla E Mayle and Nicholas R Laramee and Kerri B Brown and Janell L Bezdek and Christopher A Czaja and Ingrid R Hewitson and Shireen Banerji and Liz Lamere and Ethel V Taylor and Sarah Venti and Kristle Green and Rachel H Jervis},
journal = {MMWR. Morbidity and mortality weekly report},
year = {2026},
month = oct,
doi = {10.15585/mmwr.mm7539a2},
url = {https://europepmc.org/article/MED/42848692},
}
RIS
TY - JOUR
TI - Notes from the Field: Investigation of Unapproved Botulinum Toxin Product Administered at a Medical Spa - Colorado, 2025-2026.
AU - Pallavi Oruganti
AU - Natalia G Riemer
AU - Cayla E Mayle
AU - Nicholas R Laramee
AU - Kerri B Brown
AU - Janell L Bezdek
AU - Christopher A Czaja
AU - Ingrid R Hewitson
AU - Shireen Banerji
AU - Liz Lamere
AU - Ethel V Taylor
AU - Sarah Venti
AU - Kristle Green
AU - Rachel H Jervis
PY - 2026
DA - 2026/10/08
JO - MMWR. Morbidity and mortality weekly report
DO - 10.15585/mmwr.mm7539a2
UR - https://europepmc.org/article/MED/42848692
SN - 0149-2195
SN - 1545-861X
ER -